Enhanced immunogenicity of a Clostridioides difficile TcdB vaccine adjuvanted with a synthetic dual-TLR ligand adjuvant.
Farha Naz, Nicholas Hagspiel, Feifan Xu, Brandon A. Thompson, G. Brett Moreau, Mary Young, Joel F. Herbein, Christopher B. Fox, William A. Petri, Mayuresh M. Abhyankar
This paper evaluates a TcdB vaccine adjuvanted with a dual-TLR ligand liposome, showing complete protection against lethal CDI in mice and superior antibody and memory B cell responses compared to alum.
npj Vaccines · Feb 18, 2025Peer-reviewedImmunology